Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry.

Jung BH, Rezk NL, Bridges AS, Corbett AH, Kashuba AD.

Biomed Chromatogr. 2007 Oct;21(10):1095-104.

PMID:
17582235
2.

Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM.

J Infect Dis. 2007 Mar 1;195(5):698-702. Epub 2007 Jan 22.

PMID:
17262712
3.

HIV-1 drug resistance in variants from the female genital tract and plasma.

Kemal KS, Burger H, Mayers D, Anastos K, Foley B, Kitchen C, Huggins P, Schroeder T, Picchio G, Back S, Gao W, Meyer WA 3rd, Weiser B.

J Infect Dis. 2007 Feb 15;195(4):535-45. Epub 2007 Jan 8.

PMID:
17230413
4.

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.

Neely MN, Benning L, Xu J, Strickler HD, Greenblatt RM, Minkoff H, Young M, Bremer J, Levine AM, Kovacs A.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):38-42.

5.

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

Subbarao S, Otten RA, Ramos A, Kim C, Jackson E, Monsour M, Adams DR, Bashirian S, Johnson J, Soriano V, Rendon A, Hudgens MG, Butera S, Janssen R, Paxton L, Greenberg AE, Folks TM.

J Infect Dis. 2006 Oct 1;194(7):904-11. Epub 2006 Aug 29.

PMID:
16960777
8.

Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction.

Rezk NL, Crutchley RD, Kashuba AD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5;822(1-2):201-8.

PMID:
16005269
9.

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection.

Wang LH, Begley J, St Claire RL 3rd, Harris J, Wakeford C, Rousseau FS.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1173-82.

PMID:
15588339
10.

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women.

Min SS, Corbett AH, Rezk N, Cu-Uvin S, Fiscus SA, Petch L, Cohen MS, Kashuba AD.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1577-80.

PMID:
15577412
11.
12.

Evaluation of antiretroviral drug measurements by an interlaboratory quality control program.

Droste JA, Aarnoutse RE, Koopmans PP, Hekster YA, Burger DM.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):287-91.

PMID:
12626888
13.

Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.

Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML.

J Infect Dis. 2002 Nov 15;186(10):1508-13. Epub 2002 Oct 29.

PMID:
12404171
14.

Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?

Hosseinipour M, Cohen MS, Vernazza PL, Kashuba AD.

Clin Infect Dis. 2002 May 15;34(10):1391-5. Epub 2002 Apr 22.

PMID:
11981736
15.

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.

Fletcher CV, Anderson PL, Kakuda TN, Schacker TW, Henry K, Gross CR, Brundage RC.

AIDS. 2002 Mar 8;16(4):551-60.

PMID:
11872998
16.

Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women.

Kaydos SC, Swygard H, Wise SL, Sena AC, Leone PA, Miller WC, Cohen MS, Hobbs MM.

J Clin Microbiol. 2002 Jan;40(1):89-95.

17.

Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

Otten RA, Smith DK, Adams DR, Pullium JK, Jackson E, Kim CN, Jaffe H, Janssen R, Butera S, Folks TM.

J Virol. 2000 Oct;74(20):9771-5.

18.

Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges.

Moretti MV, Pauluzzi S, Cesana M.

Antimicrob Agents Chemother. 2000 Jan;44(1):73-7.

19.

Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV.

Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG.

AIDS. 1998 Sep 10;12(13):1699-706.

PMID:
9764791
20.

Concentration-controlled zidovudine therapy.

Fletcher CV, Acosta EP, Henry K, Page LM, Gross CR, Kawle SP, Remmel RP, Erice A, Balfour HH Jr.

Clin Pharmacol Ther. 1998 Sep;64(3):331-8.

PMID:
9757157

Supplemental Content

Support Center